Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Kangmei Pharmaceutical CoSHSE:600518 48 OCF Yield % is 0.85 as of Jul. 30, 2026, which is 193% above its 10-year median of 0.29. GuruFocus rates SHSE:600518 with a GF Score™ of 48/100 and a GF Value™ of ¥1.46 (Fairly Valued). The stock has 2 warning signs investors should review. Among 1,007 Drug Manufacturers companies, Kangmei Pharmaceutical Co ranks worse than 65.64% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Kangmei Pharmaceutical Co OCF Yield % Related Terms
Kangmei Pharmaceutical Co OCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Kangmei Pharmaceutical Co's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kangmei Pharmaceutical Co OCF Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Kangmei Pharmaceutical Co's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Kangmei Pharmaceutical Co's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kangmei Pharmaceutical Co (SHSE:600518) has a OCF Yield % of 0.85 as of Jul. 30, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Kangmei Pharmaceutical Co and its competitors. This is 193% above median its historical median of 0.29. According to the industry distribution chart, Kangmei Pharmaceutical Co ranks #661 out of 1007 companies in the Drug Manufacturers industry, placing it in the top 65.6%.
Is Kangmei Pharmaceutical Co's OCF Yield % too high?
Kangmei Pharmaceutical Co's current OCF Yield % of 0.85 is 193% above median its 10-year median of 0.29. The Drug Manufacturers industry median OCF Yield % is 3.59. Kangmei Pharmaceutical Co's value of 0.85 is 76.3% below this industry median. Based on the distribution chart, Kangmei Pharmaceutical Co ranks #661 out of 1007 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Kangmei Pharmaceutical Co has a GF Score™ of 48/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Kangmei Pharmaceutical Co's OCF Yield % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Kangmei Pharmaceutical Co ranks #661 out of 1007 companies for OCF Yield %. This places Kangmei Pharmaceutical Co in the lower half of its industry. The industry median OCF Yield % is 3.59. Kangmei Pharmaceutical Co's value of 0.85 is 76.3% below this benchmark. While the company's 10-year median is 0.29 vs. the industry median of 3.59, Kangmei Pharmaceutical Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Drug Manufacturers company?
The median OCF Yield % among Drug Manufacturers companies is 3.59, based on 1,007 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kangmei Pharmaceutical Co's current OCF Yield % of 0.85 is 76.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Kangmei Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median OCF Yield % is 3.59 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kangmei Pharmaceutical Co's current OCF Yield % is 0.85, which is 193% above median its own 10-year median of 0.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kangmei Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Kangmei Pharmaceutical Co (SHSE:600518) is currently considered Fairly Valued. The stock's GF Value™ is ¥1.46, compared to a current price of ¥1.35 — trading 7.5% below its estimated fair value. The current OCF Yield % is 0.85, which is 193% above median its 10-year median of 0.29 and 76.3% below the Drug Manufacturers industry median of 3.59. Kangmei Pharmaceutical Co's overall GF Score™ is 48/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Kangmei Pharmaceutical Co (SHSE:600518), the current OCF Yield % is 0.85 as of Jul. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kangmei Pharmaceutical Co (SHSE:600518) Overvalued in 2026?
Based on GuruFocus' analysis, Kangmei Pharmaceutical Co stock appears to be undervalued.
The current stock price of ¥1.35 is trading 7.5% below its estimated GF Value™ of ¥1.46.
GuruFocus considers Kangmei Pharmaceutical Co to be Fairly Valued.
Key valuation signals for SHSE:600518:
OCF Yield %: 0.85 (193% above median its 10-year median of 0.29)
GF Value™: ¥1.46 vs. price of ¥1.35 (7.5% below fair value)
Industry Position: 76.3% below the Drug Manufacturers median (#661 of 1007)
No single metric tells the full story. See the SHSE:600518 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kangmei Pharmaceutical Co Ltd is a pharmaceutical company engaged in the trading of Chinese herbal medicines, production and sales of Chinese herbal medicine slices, Chinese patent medicine preparations, health foods, chemical drugs, and medical devices, modern pharmaceutical logistics system. The company is also engaged in medical equipment, property leasing and sales, and other services.
48GF Score
Get the complete analysis for SHSE:600518
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600518 has been successfully added to your 
